ShockWave Medical Stock: Robust Growth But Overvalued (NASDA

The approval to distribute products in China to significantly boost revenue growth in the coming quarters. See why I assign a hold rating to SWAV stock.

Related Keywords

Germany , United States , United Kingdom , China , Austria , Canada , Switzerland , France , America , Chinese , Danai Jetawattana , Doug Godshall , China National Medical Products Administration , Company Overview , Shockwave Medical Inc , Nasdaq , Two Asian , Wave Medical , South America , Investor Relations , Genesis Medtech , National Medical Products Administration , Chinese Expert Consensus , Calcific Coronary Lesions , Expert Consensus Statement , Chief Executive Officer , Shockwave Medical , Quant Rating ,